Lab instruments maker Agilent's Q4 revenue beats estimates

Agilent Technologies

24/11/2025 21:20

Overview

Agilent Q4 fiscal revenue grows 9.4%, beating analyst expectations

Adjusted net income for Q4 slightly beats analyst expectations

Company provides optimistic FY26 guidance, expecting revenue growth of 5% to 7%

Outlook

Agilent expects FY26 revenue between $7.3 bln and $7.4 bln

FY26 non-GAAP EPS expected between $5.86 and $6.00

Q1 FY26 revenue guidance between $1.79 bln and $1.82 bln

Result Drivers

LIFE SCIENCES GROWTH - Life Sciences and Diagnostics Markets Group reported 15% revenue growth, driven by strong demand

OPERATIONAL EFFICIENCIES - Expanded Ignite Operating System enhanced operating efficiencies, fueling innovation and commercial execution

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$1.86 bln
$1.83 bln (12 Analysts)
Q4 EPS
$1.53
Q4 Adjusted Net Income
Slight Beat*
$452 mln
$449.42 mln (11 Analysts)
Q4 Net Income
$434 mln
Q4 Pretax Profit
$442 mln


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Agilent Technologies Inc is $150.00, about 0.8% below its November 21 closing price of $151.25

Press Release: ID:nBw6q480Ba

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)